Drugs and clinical trials: new medicines, trial results and regulator decisions.
ADC development remains complex and empirical, requiring linker chemistry, DAR, and stability optimization. Eurofins Discovery offers specialized linker synthesis for clinical trials.
Tenvie Therapeutics initiated Phase 1 first-in-human trials for TNV313, a small molecule NLRP3 inhibitor designed to cross the blood-brain barrier. The company plans to publish preliminary safety and pharmacokinetic data in the first half of 2027.
The FDA warned consumers about products containing undeclared ingredients, including sildenafil (Viagra's active ingredient) and acetaminophen (Tylenol).
Researchers are testing a small interfering RNA molecule designed to reduce prion protein production. This marks the first human trial for this treatment.